Raltitrexed is a folate-based inhibitor of thymidylate synthase (TS) that is rapidly and extensively metabolized to its more potent polyglutamate derivatives. Raltitrexed is an inhibitor of DHFR.
1. Jodrell, D I., et al., 1991. The pharmacokinetics of the quinazoline antifolate ICI D 1694 in mice and rats. Cancer chemotherapy and pharmacology. 28(5): 331-8. PMID: 1914075
2. Jackman, A L., et al., . ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. European journal of cancer (Oxford, England : 1990). 31A(7-8): 1277-82. PMID: 7577036